Immunogenicity and safety of high-dose quadrivalent influenza vaccine in older adults in Taiwan: A phase III, randomized, multi-center study

Chen, Jau-YuanJau-YuanChenSZU-MIN HSIEHHwang, Shinn-JangShinn-JangHwangLiu, Chiu-ShongChiu-ShongLiuLi, XiaolingXiaolingLiFournier, MarionMarionFournierYeh, Ting-YuTing-YuYehYin, J KevinJ KevinYinSamson, Sandrine ISandrine ISamson2022-10-282022-10-282022-10-260264410Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/624132High-dose influenza vaccine offers better protection against influenza/associated complications compared with standard-dose formulation. We evaluated immunogenicity and safety of high-dose influenza vaccine (QIV-HD) and standard-dose (QIV-SD) in older adults (≥ 65 years) in Taiwan.enClinical study; High dose quadrivalent influenza vaccine; Immunogenicity; Older adults; Safety; Taiwan[SDGs]SDG3Immunogenicity and safety of high-dose quadrivalent influenza vaccine in older adults in Taiwan: A phase III, randomized, multi-center studyjournal article10.1016/j.vaccine.2022.09.078362166502-s2.0-85139692529https://api.elsevier.com/content/abstract/scopus_id/85139692529